4
Changes in Ownership
Editas Medicine, Inc. Filed Acc 0001650664-26-000009
CEO sold 5,394 shares at $2.02 ($10,894)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
O'Neill Gilmore Neil · CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-03 | Sale : show line 1 in the form 10b5-1 | −5,394 | $2.02 | $10,894 | 263,693 | D |
| Open-market sales · 5,394 sh · avg $2.02 · $10,894 | ||||||
Loading xslF345X05/wk-form4_1772661358.xml…